Loading…

Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis

Microglia are the resident mononuclear phagocytes of the central nervous system and have been implicated in the pathogenesis of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). During neurodegeneration, microglial activation is accompanied by infiltration of circulating monocy...

Full description

Saved in:
Bibliographic Details
Published in:Acta neuropathologica 2016-03, Vol.131 (3), p.465-480
Main Authors: El Oussini, Hajer, Bayer, Hanna, Scekic-Zahirovic, Jelena, Vercruysse, Pauline, Sinniger, Jérôme, Dirrig-Grosch, Sylvie, Dieterlé, Stéphane, Echaniz-Laguna, Andoni, Larmet, Yves, Müller, Kathrin, Weishaupt, Jochen H., Thal, Dietmar R., van Rheenen, Wouter, van Eijk, Kristel, Lawson, Roland, Monassier, Laurent, Maroteaux, Luc, Roumier, Anne, Wong, Philip C., van den Berg, Leonard H., Ludolph, Albert C., Veldink, Jan H., Witting, Anke, Dupuis, Luc
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c619t-aa4c37ab6022af27d0bdf460cd3d1f01e094c65fe0d37f2d1983a8c20bccca63
cites cdi_FETCH-LOGICAL-c619t-aa4c37ab6022af27d0bdf460cd3d1f01e094c65fe0d37f2d1983a8c20bccca63
container_end_page 480
container_issue 3
container_start_page 465
container_title Acta neuropathologica
container_volume 131
creator El Oussini, Hajer
Bayer, Hanna
Scekic-Zahirovic, Jelena
Vercruysse, Pauline
Sinniger, Jérôme
Dirrig-Grosch, Sylvie
Dieterlé, Stéphane
Echaniz-Laguna, Andoni
Larmet, Yves
Müller, Kathrin
Weishaupt, Jochen H.
Thal, Dietmar R.
van Rheenen, Wouter
van Eijk, Kristel
Lawson, Roland
Monassier, Laurent
Maroteaux, Luc
Roumier, Anne
Wong, Philip C.
van den Berg, Leonard H.
Ludolph, Albert C.
Veldink, Jan H.
Witting, Anke
Dupuis, Luc
description Microglia are the resident mononuclear phagocytes of the central nervous system and have been implicated in the pathogenesis of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). During neurodegeneration, microglial activation is accompanied by infiltration of circulating monocytes, leading to production of multiple inflammatory mediators in the spinal cord. Degenerative alterations in mononuclear phagocytes are commonly observed during neurodegenerative diseases, yet little is known concerning the mechanisms leading to their degeneration, or the consequences on disease progression. Here we observed that the serotonin 2B receptor (5-HT 2B ), a serotonin receptor expressed in microglia, is upregulated in the spinal cord of three different transgenic mouse models of ALS. In mutant SOD1 mice, this upregulation was restricted to cells positive for CD11b, a marker of mononuclear phagocytes. Ablation of 5-HT 2B receptor in transgenic ALS mice expressing mutant SOD1 resulted in increased degeneration of mononuclear phagocytes, as evidenced by fragmentation of Iba1-positive cellular processes. This was accompanied by decreased expression of key neuroinflammatory genes but also loss of expression of homeostatic microglial genes. Importantly, the dramatic effect of 5-HT 2B receptor ablation on mononuclear phagocytes was associated with acceleration of disease progression. To determine the translational relevance of these results, we studied polymorphisms in the human HTR2B gene, which encodes the 5-HT 2B receptor, in a large cohort of ALS patients. In this cohort, the C allele of SNP rs10199752 in HTR2B was associated with longer survival. Moreover, patients carrying one copy of the C allele of SNP rs10199752 showed increased 5-HT 2B mRNA in spinal cord and displayed less pronounced degeneration of Iba1 positive cells than patients carrying two copies of the more common A allele. Thus, the 5-HT 2B receptor limits degeneration of spinal cord mononuclear phagocytes, most likely microglia, and slows disease progression in ALS. Targeting this receptor might be therapeutically useful.
doi_str_mv 10.1007/s00401-016-1534-4
format article
fullrecord <record><control><sourceid>gale_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01253857v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A443222849</galeid><sourcerecordid>A443222849</sourcerecordid><originalsourceid>FETCH-LOGICAL-c619t-aa4c37ab6022af27d0bdf460cd3d1f01e094c65fe0d37f2d1983a8c20bccca63</originalsourceid><addsrcrecordid>eNqNks1uEzEQx1cIREPhAbggS1zgsMXfuzmGilKkSBzo3XLs2cTVrr3Ym6K8BY_MbFMiQCBhH6yZ-c14_PdU1UtGLxilzbtCqaSspkzXTAlZy0fVgknBa6qEeFwtKMWoFpyfVc9KuUWLN1I9rc64bqQUii2q718gpynFEAl_TzI4GKeUSenTt0J8KGALkDGnbYZSQorERo823EGcEIAtRMh2miOpI2UM0fbEpezJkGKKe9eDzWTc2W1yhwkKwYvscEhTTuMuONLbCfN7UhDMqYTyvHrS2b7Ai4fzvLq5-nBzeV2vP3_8dLla106z5VRbK51o7EZTzm3HG083vpOaOi886ygDupROqw6oF03HPVu2wraO041zzmpxXr09lt3Z3ow5DDYfTLLBXK_WZvahVkq0qrljyL45sqjD1z2UyQyhOOh7GyHti2GNblWrNaf_gyrV4vdIRF__gd6mfUb57im5VFTgOlFb24MJsUPlrJuLmhV-Iee8lUukLv5C4fYwBJcidAH9vyWwY4JD0UuG7qQBo2aeLXOcLZRBm3m2zNzwq4eG95sB_Cnj5zAhwI9AwVDcQv7lRf-s-gOQVtoE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1764950333</pqid></control><display><type>article</type><title>Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis</title><source>Springer Nature</source><creator>El Oussini, Hajer ; Bayer, Hanna ; Scekic-Zahirovic, Jelena ; Vercruysse, Pauline ; Sinniger, Jérôme ; Dirrig-Grosch, Sylvie ; Dieterlé, Stéphane ; Echaniz-Laguna, Andoni ; Larmet, Yves ; Müller, Kathrin ; Weishaupt, Jochen H. ; Thal, Dietmar R. ; van Rheenen, Wouter ; van Eijk, Kristel ; Lawson, Roland ; Monassier, Laurent ; Maroteaux, Luc ; Roumier, Anne ; Wong, Philip C. ; van den Berg, Leonard H. ; Ludolph, Albert C. ; Veldink, Jan H. ; Witting, Anke ; Dupuis, Luc</creator><creatorcontrib>El Oussini, Hajer ; Bayer, Hanna ; Scekic-Zahirovic, Jelena ; Vercruysse, Pauline ; Sinniger, Jérôme ; Dirrig-Grosch, Sylvie ; Dieterlé, Stéphane ; Echaniz-Laguna, Andoni ; Larmet, Yves ; Müller, Kathrin ; Weishaupt, Jochen H. ; Thal, Dietmar R. ; van Rheenen, Wouter ; van Eijk, Kristel ; Lawson, Roland ; Monassier, Laurent ; Maroteaux, Luc ; Roumier, Anne ; Wong, Philip C. ; van den Berg, Leonard H. ; Ludolph, Albert C. ; Veldink, Jan H. ; Witting, Anke ; Dupuis, Luc</creatorcontrib><description>Microglia are the resident mononuclear phagocytes of the central nervous system and have been implicated in the pathogenesis of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). During neurodegeneration, microglial activation is accompanied by infiltration of circulating monocytes, leading to production of multiple inflammatory mediators in the spinal cord. Degenerative alterations in mononuclear phagocytes are commonly observed during neurodegenerative diseases, yet little is known concerning the mechanisms leading to their degeneration, or the consequences on disease progression. Here we observed that the serotonin 2B receptor (5-HT 2B ), a serotonin receptor expressed in microglia, is upregulated in the spinal cord of three different transgenic mouse models of ALS. In mutant SOD1 mice, this upregulation was restricted to cells positive for CD11b, a marker of mononuclear phagocytes. Ablation of 5-HT 2B receptor in transgenic ALS mice expressing mutant SOD1 resulted in increased degeneration of mononuclear phagocytes, as evidenced by fragmentation of Iba1-positive cellular processes. This was accompanied by decreased expression of key neuroinflammatory genes but also loss of expression of homeostatic microglial genes. Importantly, the dramatic effect of 5-HT 2B receptor ablation on mononuclear phagocytes was associated with acceleration of disease progression. To determine the translational relevance of these results, we studied polymorphisms in the human HTR2B gene, which encodes the 5-HT 2B receptor, in a large cohort of ALS patients. In this cohort, the C allele of SNP rs10199752 in HTR2B was associated with longer survival. Moreover, patients carrying one copy of the C allele of SNP rs10199752 showed increased 5-HT 2B mRNA in spinal cord and displayed less pronounced degeneration of Iba1 positive cells than patients carrying two copies of the more common A allele. Thus, the 5-HT 2B receptor limits degeneration of spinal cord mononuclear phagocytes, most likely microglia, and slows disease progression in ALS. Targeting this receptor might be therapeutically useful.</description><identifier>ISSN: 0001-6322</identifier><identifier>EISSN: 1432-0533</identifier><identifier>DOI: 10.1007/s00401-016-1534-4</identifier><identifier>PMID: 26744351</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Ablation ; Amyotrophic lateral sclerosis ; Amyotrophic Lateral Sclerosis - metabolism ; Amyotrophic Lateral Sclerosis - pathology ; Animal genetics ; Animals ; Biochemistry, Molecular Biology ; Cardiology and cardiovascular system ; Development and progression ; Disease ; Disease Models, Animal ; Disease Progression ; Female ; Genetic engineering ; Genetic polymorphisms ; Genetics ; Human health and pathology ; Humans ; Life Sciences ; Male ; Medicine ; Medicine &amp; Public Health ; Mice ; Mice, Transgenic ; Microglia - pathology ; Molecular biology ; Mononuclear Phagocyte System - metabolism ; Mononuclear Phagocyte System - pathology ; Motor Neurons - pathology ; Nervous system diseases ; Neurobiology ; Neurodegeneration ; Neurology ; Neurons ; Neurons and Cognition ; Neuropathology ; Neurosciences ; Original Paper ; Pathology ; Pharmaceutical sciences ; Pharmacology ; Phenols (Class of compounds) ; Psychiatrics and mental health ; Pulmonology and respiratory tract ; Real-Time Polymerase Chain Reaction ; Receptor, Serotonin, 5-HT2B - metabolism ; Serotonin ; Spinal cord ; Spinal Cord - pathology</subject><ispartof>Acta neuropathologica, 2016-03, Vol.131 (3), p.465-480</ispartof><rights>Springer-Verlag Berlin Heidelberg 2016</rights><rights>COPYRIGHT 2016 Springer</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c619t-aa4c37ab6022af27d0bdf460cd3d1f01e094c65fe0d37f2d1983a8c20bccca63</citedby><cites>FETCH-LOGICAL-c619t-aa4c37ab6022af27d0bdf460cd3d1f01e094c65fe0d37f2d1983a8c20bccca63</cites><orcidid>0000-0002-9499-8603 ; 0000-0003-1012-9783</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26744351$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-01253857$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>El Oussini, Hajer</creatorcontrib><creatorcontrib>Bayer, Hanna</creatorcontrib><creatorcontrib>Scekic-Zahirovic, Jelena</creatorcontrib><creatorcontrib>Vercruysse, Pauline</creatorcontrib><creatorcontrib>Sinniger, Jérôme</creatorcontrib><creatorcontrib>Dirrig-Grosch, Sylvie</creatorcontrib><creatorcontrib>Dieterlé, Stéphane</creatorcontrib><creatorcontrib>Echaniz-Laguna, Andoni</creatorcontrib><creatorcontrib>Larmet, Yves</creatorcontrib><creatorcontrib>Müller, Kathrin</creatorcontrib><creatorcontrib>Weishaupt, Jochen H.</creatorcontrib><creatorcontrib>Thal, Dietmar R.</creatorcontrib><creatorcontrib>van Rheenen, Wouter</creatorcontrib><creatorcontrib>van Eijk, Kristel</creatorcontrib><creatorcontrib>Lawson, Roland</creatorcontrib><creatorcontrib>Monassier, Laurent</creatorcontrib><creatorcontrib>Maroteaux, Luc</creatorcontrib><creatorcontrib>Roumier, Anne</creatorcontrib><creatorcontrib>Wong, Philip C.</creatorcontrib><creatorcontrib>van den Berg, Leonard H.</creatorcontrib><creatorcontrib>Ludolph, Albert C.</creatorcontrib><creatorcontrib>Veldink, Jan H.</creatorcontrib><creatorcontrib>Witting, Anke</creatorcontrib><creatorcontrib>Dupuis, Luc</creatorcontrib><title>Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis</title><title>Acta neuropathologica</title><addtitle>Acta Neuropathol</addtitle><addtitle>Acta Neuropathol</addtitle><description>Microglia are the resident mononuclear phagocytes of the central nervous system and have been implicated in the pathogenesis of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). During neurodegeneration, microglial activation is accompanied by infiltration of circulating monocytes, leading to production of multiple inflammatory mediators in the spinal cord. Degenerative alterations in mononuclear phagocytes are commonly observed during neurodegenerative diseases, yet little is known concerning the mechanisms leading to their degeneration, or the consequences on disease progression. Here we observed that the serotonin 2B receptor (5-HT 2B ), a serotonin receptor expressed in microglia, is upregulated in the spinal cord of three different transgenic mouse models of ALS. In mutant SOD1 mice, this upregulation was restricted to cells positive for CD11b, a marker of mononuclear phagocytes. Ablation of 5-HT 2B receptor in transgenic ALS mice expressing mutant SOD1 resulted in increased degeneration of mononuclear phagocytes, as evidenced by fragmentation of Iba1-positive cellular processes. This was accompanied by decreased expression of key neuroinflammatory genes but also loss of expression of homeostatic microglial genes. Importantly, the dramatic effect of 5-HT 2B receptor ablation on mononuclear phagocytes was associated with acceleration of disease progression. To determine the translational relevance of these results, we studied polymorphisms in the human HTR2B gene, which encodes the 5-HT 2B receptor, in a large cohort of ALS patients. In this cohort, the C allele of SNP rs10199752 in HTR2B was associated with longer survival. Moreover, patients carrying one copy of the C allele of SNP rs10199752 showed increased 5-HT 2B mRNA in spinal cord and displayed less pronounced degeneration of Iba1 positive cells than patients carrying two copies of the more common A allele. Thus, the 5-HT 2B receptor limits degeneration of spinal cord mononuclear phagocytes, most likely microglia, and slows disease progression in ALS. Targeting this receptor might be therapeutically useful.</description><subject>Ablation</subject><subject>Amyotrophic lateral sclerosis</subject><subject>Amyotrophic Lateral Sclerosis - metabolism</subject><subject>Amyotrophic Lateral Sclerosis - pathology</subject><subject>Animal genetics</subject><subject>Animals</subject><subject>Biochemistry, Molecular Biology</subject><subject>Cardiology and cardiovascular system</subject><subject>Development and progression</subject><subject>Disease</subject><subject>Disease Models, Animal</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Genetic engineering</subject><subject>Genetic polymorphisms</subject><subject>Genetics</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Microglia - pathology</subject><subject>Molecular biology</subject><subject>Mononuclear Phagocyte System - metabolism</subject><subject>Mononuclear Phagocyte System - pathology</subject><subject>Motor Neurons - pathology</subject><subject>Nervous system diseases</subject><subject>Neurobiology</subject><subject>Neurodegeneration</subject><subject>Neurology</subject><subject>Neurons</subject><subject>Neurons and Cognition</subject><subject>Neuropathology</subject><subject>Neurosciences</subject><subject>Original Paper</subject><subject>Pathology</subject><subject>Pharmaceutical sciences</subject><subject>Pharmacology</subject><subject>Phenols (Class of compounds)</subject><subject>Psychiatrics and mental health</subject><subject>Pulmonology and respiratory tract</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>Receptor, Serotonin, 5-HT2B - metabolism</subject><subject>Serotonin</subject><subject>Spinal cord</subject><subject>Spinal Cord - pathology</subject><issn>0001-6322</issn><issn>1432-0533</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNks1uEzEQx1cIREPhAbggS1zgsMXfuzmGilKkSBzo3XLs2cTVrr3Ym6K8BY_MbFMiQCBhH6yZ-c14_PdU1UtGLxilzbtCqaSspkzXTAlZy0fVgknBa6qEeFwtKMWoFpyfVc9KuUWLN1I9rc64bqQUii2q718gpynFEAl_TzI4GKeUSenTt0J8KGALkDGnbYZSQorERo823EGcEIAtRMh2miOpI2UM0fbEpezJkGKKe9eDzWTc2W1yhwkKwYvscEhTTuMuONLbCfN7UhDMqYTyvHrS2b7Ai4fzvLq5-nBzeV2vP3_8dLla106z5VRbK51o7EZTzm3HG083vpOaOi886ygDupROqw6oF03HPVu2wraO041zzmpxXr09lt3Z3ow5DDYfTLLBXK_WZvahVkq0qrljyL45sqjD1z2UyQyhOOh7GyHti2GNblWrNaf_gyrV4vdIRF__gd6mfUb57im5VFTgOlFb24MJsUPlrJuLmhV-Iee8lUukLv5C4fYwBJcidAH9vyWwY4JD0UuG7qQBo2aeLXOcLZRBm3m2zNzwq4eG95sB_Cnj5zAhwI9AwVDcQv7lRf-s-gOQVtoE</recordid><startdate>20160301</startdate><enddate>20160301</enddate><creator>El Oussini, Hajer</creator><creator>Bayer, Hanna</creator><creator>Scekic-Zahirovic, Jelena</creator><creator>Vercruysse, Pauline</creator><creator>Sinniger, Jérôme</creator><creator>Dirrig-Grosch, Sylvie</creator><creator>Dieterlé, Stéphane</creator><creator>Echaniz-Laguna, Andoni</creator><creator>Larmet, Yves</creator><creator>Müller, Kathrin</creator><creator>Weishaupt, Jochen H.</creator><creator>Thal, Dietmar R.</creator><creator>van Rheenen, Wouter</creator><creator>van Eijk, Kristel</creator><creator>Lawson, Roland</creator><creator>Monassier, Laurent</creator><creator>Maroteaux, Luc</creator><creator>Roumier, Anne</creator><creator>Wong, Philip C.</creator><creator>van den Berg, Leonard H.</creator><creator>Ludolph, Albert C.</creator><creator>Veldink, Jan H.</creator><creator>Witting, Anke</creator><creator>Dupuis, Luc</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><general>Springer Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>7T5</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-9499-8603</orcidid><orcidid>https://orcid.org/0000-0003-1012-9783</orcidid></search><sort><creationdate>20160301</creationdate><title>Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis</title><author>El Oussini, Hajer ; Bayer, Hanna ; Scekic-Zahirovic, Jelena ; Vercruysse, Pauline ; Sinniger, Jérôme ; Dirrig-Grosch, Sylvie ; Dieterlé, Stéphane ; Echaniz-Laguna, Andoni ; Larmet, Yves ; Müller, Kathrin ; Weishaupt, Jochen H. ; Thal, Dietmar R. ; van Rheenen, Wouter ; van Eijk, Kristel ; Lawson, Roland ; Monassier, Laurent ; Maroteaux, Luc ; Roumier, Anne ; Wong, Philip C. ; van den Berg, Leonard H. ; Ludolph, Albert C. ; Veldink, Jan H. ; Witting, Anke ; Dupuis, Luc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c619t-aa4c37ab6022af27d0bdf460cd3d1f01e094c65fe0d37f2d1983a8c20bccca63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Ablation</topic><topic>Amyotrophic lateral sclerosis</topic><topic>Amyotrophic Lateral Sclerosis - metabolism</topic><topic>Amyotrophic Lateral Sclerosis - pathology</topic><topic>Animal genetics</topic><topic>Animals</topic><topic>Biochemistry, Molecular Biology</topic><topic>Cardiology and cardiovascular system</topic><topic>Development and progression</topic><topic>Disease</topic><topic>Disease Models, Animal</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Genetic engineering</topic><topic>Genetic polymorphisms</topic><topic>Genetics</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Microglia - pathology</topic><topic>Molecular biology</topic><topic>Mononuclear Phagocyte System - metabolism</topic><topic>Mononuclear Phagocyte System - pathology</topic><topic>Motor Neurons - pathology</topic><topic>Nervous system diseases</topic><topic>Neurobiology</topic><topic>Neurodegeneration</topic><topic>Neurology</topic><topic>Neurons</topic><topic>Neurons and Cognition</topic><topic>Neuropathology</topic><topic>Neurosciences</topic><topic>Original Paper</topic><topic>Pathology</topic><topic>Pharmaceutical sciences</topic><topic>Pharmacology</topic><topic>Phenols (Class of compounds)</topic><topic>Psychiatrics and mental health</topic><topic>Pulmonology and respiratory tract</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>Receptor, Serotonin, 5-HT2B - metabolism</topic><topic>Serotonin</topic><topic>Spinal cord</topic><topic>Spinal Cord - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>El Oussini, Hajer</creatorcontrib><creatorcontrib>Bayer, Hanna</creatorcontrib><creatorcontrib>Scekic-Zahirovic, Jelena</creatorcontrib><creatorcontrib>Vercruysse, Pauline</creatorcontrib><creatorcontrib>Sinniger, Jérôme</creatorcontrib><creatorcontrib>Dirrig-Grosch, Sylvie</creatorcontrib><creatorcontrib>Dieterlé, Stéphane</creatorcontrib><creatorcontrib>Echaniz-Laguna, Andoni</creatorcontrib><creatorcontrib>Larmet, Yves</creatorcontrib><creatorcontrib>Müller, Kathrin</creatorcontrib><creatorcontrib>Weishaupt, Jochen H.</creatorcontrib><creatorcontrib>Thal, Dietmar R.</creatorcontrib><creatorcontrib>van Rheenen, Wouter</creatorcontrib><creatorcontrib>van Eijk, Kristel</creatorcontrib><creatorcontrib>Lawson, Roland</creatorcontrib><creatorcontrib>Monassier, Laurent</creatorcontrib><creatorcontrib>Maroteaux, Luc</creatorcontrib><creatorcontrib>Roumier, Anne</creatorcontrib><creatorcontrib>Wong, Philip C.</creatorcontrib><creatorcontrib>van den Berg, Leonard H.</creatorcontrib><creatorcontrib>Ludolph, Albert C.</creatorcontrib><creatorcontrib>Veldink, Jan H.</creatorcontrib><creatorcontrib>Witting, Anke</creatorcontrib><creatorcontrib>Dupuis, Luc</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Acta neuropathologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>El Oussini, Hajer</au><au>Bayer, Hanna</au><au>Scekic-Zahirovic, Jelena</au><au>Vercruysse, Pauline</au><au>Sinniger, Jérôme</au><au>Dirrig-Grosch, Sylvie</au><au>Dieterlé, Stéphane</au><au>Echaniz-Laguna, Andoni</au><au>Larmet, Yves</au><au>Müller, Kathrin</au><au>Weishaupt, Jochen H.</au><au>Thal, Dietmar R.</au><au>van Rheenen, Wouter</au><au>van Eijk, Kristel</au><au>Lawson, Roland</au><au>Monassier, Laurent</au><au>Maroteaux, Luc</au><au>Roumier, Anne</au><au>Wong, Philip C.</au><au>van den Berg, Leonard H.</au><au>Ludolph, Albert C.</au><au>Veldink, Jan H.</au><au>Witting, Anke</au><au>Dupuis, Luc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis</atitle><jtitle>Acta neuropathologica</jtitle><stitle>Acta Neuropathol</stitle><addtitle>Acta Neuropathol</addtitle><date>2016-03-01</date><risdate>2016</risdate><volume>131</volume><issue>3</issue><spage>465</spage><epage>480</epage><pages>465-480</pages><issn>0001-6322</issn><eissn>1432-0533</eissn><abstract>Microglia are the resident mononuclear phagocytes of the central nervous system and have been implicated in the pathogenesis of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). During neurodegeneration, microglial activation is accompanied by infiltration of circulating monocytes, leading to production of multiple inflammatory mediators in the spinal cord. Degenerative alterations in mononuclear phagocytes are commonly observed during neurodegenerative diseases, yet little is known concerning the mechanisms leading to their degeneration, or the consequences on disease progression. Here we observed that the serotonin 2B receptor (5-HT 2B ), a serotonin receptor expressed in microglia, is upregulated in the spinal cord of three different transgenic mouse models of ALS. In mutant SOD1 mice, this upregulation was restricted to cells positive for CD11b, a marker of mononuclear phagocytes. Ablation of 5-HT 2B receptor in transgenic ALS mice expressing mutant SOD1 resulted in increased degeneration of mononuclear phagocytes, as evidenced by fragmentation of Iba1-positive cellular processes. This was accompanied by decreased expression of key neuroinflammatory genes but also loss of expression of homeostatic microglial genes. Importantly, the dramatic effect of 5-HT 2B receptor ablation on mononuclear phagocytes was associated with acceleration of disease progression. To determine the translational relevance of these results, we studied polymorphisms in the human HTR2B gene, which encodes the 5-HT 2B receptor, in a large cohort of ALS patients. In this cohort, the C allele of SNP rs10199752 in HTR2B was associated with longer survival. Moreover, patients carrying one copy of the C allele of SNP rs10199752 showed increased 5-HT 2B mRNA in spinal cord and displayed less pronounced degeneration of Iba1 positive cells than patients carrying two copies of the more common A allele. Thus, the 5-HT 2B receptor limits degeneration of spinal cord mononuclear phagocytes, most likely microglia, and slows disease progression in ALS. Targeting this receptor might be therapeutically useful.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>26744351</pmid><doi>10.1007/s00401-016-1534-4</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0002-9499-8603</orcidid><orcidid>https://orcid.org/0000-0003-1012-9783</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0001-6322
ispartof Acta neuropathologica, 2016-03, Vol.131 (3), p.465-480
issn 0001-6322
1432-0533
language eng
recordid cdi_hal_primary_oai_HAL_hal_01253857v1
source Springer Nature
subjects Ablation
Amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis - metabolism
Amyotrophic Lateral Sclerosis - pathology
Animal genetics
Animals
Biochemistry, Molecular Biology
Cardiology and cardiovascular system
Development and progression
Disease
Disease Models, Animal
Disease Progression
Female
Genetic engineering
Genetic polymorphisms
Genetics
Human health and pathology
Humans
Life Sciences
Male
Medicine
Medicine & Public Health
Mice
Mice, Transgenic
Microglia - pathology
Molecular biology
Mononuclear Phagocyte System - metabolism
Mononuclear Phagocyte System - pathology
Motor Neurons - pathology
Nervous system diseases
Neurobiology
Neurodegeneration
Neurology
Neurons
Neurons and Cognition
Neuropathology
Neurosciences
Original Paper
Pathology
Pharmaceutical sciences
Pharmacology
Phenols (Class of compounds)
Psychiatrics and mental health
Pulmonology and respiratory tract
Real-Time Polymerase Chain Reaction
Receptor, Serotonin, 5-HT2B - metabolism
Serotonin
Spinal cord
Spinal Cord - pathology
title Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T07%3A34%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serotonin%202B%20receptor%20slows%20disease%20progression%20and%20prevents%20degeneration%20of%20spinal%20cord%20mononuclear%20phagocytes%20in%20amyotrophic%20lateral%20sclerosis&rft.jtitle=Acta%20neuropathologica&rft.au=El%20Oussini,%20Hajer&rft.date=2016-03-01&rft.volume=131&rft.issue=3&rft.spage=465&rft.epage=480&rft.pages=465-480&rft.issn=0001-6322&rft.eissn=1432-0533&rft_id=info:doi/10.1007/s00401-016-1534-4&rft_dat=%3Cgale_hal_p%3EA443222849%3C/gale_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c619t-aa4c37ab6022af27d0bdf460cd3d1f01e094c65fe0d37f2d1983a8c20bccca63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1764950333&rft_id=info:pmid/26744351&rft_galeid=A443222849&rfr_iscdi=true